The Ubiquitin & friends Symposium organized by the SFB F79 Targeted Protein Degradation is an international meeting, taking place in the beautiful capital of Austria and aims to bring together scholars from various fields of ubiquitin and Targeted Protein Degradation research.
The aim of this meeting on February 25th, 2022, is to initiate a scientific dialogue, exchange of know-how about new technologies, and open opportunities for collaboration between groups and institutes around Vienna.
The Austrian Science Fund (FWF) has awarded a special research programme (SFB) grant to six research groups from the Max Perutz Labs and scientists from the Institute of Molecular Biotechnology (IMBA), the Institute for Science and Technology Austria (IST), and the Johannes Kepler University Linz, Austria (JKU). The program is coordinated by Verena Jantsch and aims to gain novel mechanistic insights into the fundamental biological process of meiosis.
Congratulations to Anete Romanauska who has been awarded the Science & SciLifeLab Prize for Young Scientists in the category “Cell and Molecular Biology”. The international award was created by Science magazine/AAAS and the Swedish research center SciLifeLab with the goal to recognize excellent PhD theses in the life sciences. As part of her prize, Anete has published an essay in Science about her contributions to our understanding of the lipid metabolism of the nuclear envelope.
Congratulations to Karl Kuchler and Thomas Leonard who have been appointed Professors in the subject field of Molecular Biology by the Medical University of Vienna, and Thomas Juffmann who has been promoted to Associate Professor at the University of Vienna.
Rare diseases are usually caused by a single genetic defect. Nevertheless, the search for the cause and the assessment of the effects is highly complex and difficult. Jörg Menche’s lab has now developed a multiplex network that maps all genes and their interactions on multiple levels of biological organization. Their study, published in Nature Communications, could help scientists better diagnose the causative genetic defects in disease, as well as understand the underlying mechanisms.
The Max Perutz Labs are embedded in the Vienna BioCenter, providing access to outstanding core facilities shared by all members of the campus in addition to facilities unique to our institute.
With a strong molecular focus and a diversity of model organisms, we aim to bridge basic research with biomedicine.
To honour an extraordinary teacher and scientist, the Max Perutz Labs were named after Max Ferdinand Perutz, who, together with John C. Kendrew, was awarded the 1962 Nobel Prize in Chemistry for his studies on the structure of globular proteins ...
The Max Perutz Labs are an international research institution in which people from all over the world come together to conduct scientific research. The Perutz recognizes and respects diversity as an important asset in establishing an inclusive and productive work environment for all parties, may it be students, scientists or support staff. We are committed to a workplace that values diversity and internationality, where people from various backgrounds and perspectives feel welcome and are supported in a safe environment. Whether it be race, ethnicity, national origin, religion, social background, age, gender, sexual orientation or disability - we aim to establish a community in which everyone feels included and is treated fairly and respectfully. We believe that there is always room for improvement and that a statement is worth nothing without action, but we continuously strive to do better and encourage every individual to play an active role in creating this environment.
The Max Perutz Labs seek to educate students to think critically and analytically, challenge them to set ambitious goals, and instill in them both broad horizons and deep understanding. In doing so, we aspire to furnish them with the necessary knowledge and skills to push forward the frontiers of 21st century biomedical science.